QXO (QXO) had the highest return between February 1, 2012 and June 30, 2013 by a large-cap US stock, returning 405,654.7%.
| ASSET | DATE | % RETURN |
|---|---|---|
QXO (QXO) | 2/1/2012 - 6/30/2013 | 405,654.72% |
Genmab A-S (GMAB) | 2/1/2012 - 6/30/2013 | 335.78% |
Tesla (TSLA) | 2/1/2012 - 6/30/2013 | 269.31% |
Ionis Pharmaceuticals (IONS) | 2/1/2012 - 6/30/2013 | 226.49% |
Alnylam Pharmaceuticals (ALNY) | 2/1/2012 - 6/30/2013 | 166.32% |
PulteGroup (PHM) | 2/1/2012 - 6/30/2013 | 150.92% |
Regeneron Pharmaceuticals (REGN) | 2/1/2012 - 6/30/2013 | 148.6% |
Constellation Brands Inc Class A (STZ) | 2/1/2012 - 6/30/2013 | 147.13% |
Insmed (INSM) | 2/1/2012 - 6/30/2013 | 146.6% |
Corpay (CPAY) | 2/1/2012 - 6/30/2013 | 137.79% |
Builders FirstSource (BLDR) | 2/1/2012 - 6/30/2013 | 133.59% |
Guidewire Software (GWRE) | 2/1/2012 - 6/30/2013 | 131.17% |
CoStar (CSGP) | 2/1/2012 - 6/30/2013 | 126.92% |
Gap (GAP) | 2/1/2012 - 6/30/2013 | 123.13% |
Contura Energy (CTRA) | 2/1/2012 - 6/30/2013 | 121.37% |
Cheniere Energy (LNG) | 2/1/2012 - 6/30/2013 | 116.37% |
Tenet Healthcare (THC) | 2/1/2012 - 6/30/2013 | 116.23% |
Vertex Pharmaceuticals (VRTX) | 2/1/2012 - 6/30/2013 | 113.78% |
Charter Communications (CHTR) | 2/1/2012 - 6/30/2013 | 113.68% |
Gilead Sciences (GILD) | 2/1/2012 - 6/30/2013 | 109.05% |
Nomura Holdings Inc ADR (NMR) | 2/1/2012 - 6/30/2013 | 106.74% |
DexCom (DXCM) | 2/1/2012 - 6/30/2013 | 102.98% |
Seagate Technology (STX) | 2/1/2012 - 6/30/2013 | 102.05% |
MasTec (MTZ) | 2/1/2012 - 6/30/2013 | 99.76% |
EPAM Systems (EPAM) | 2/1/2012 - 6/30/2013 | 97.67% |
Large-cap stocks are treated as having a market cap of $10B+.
